Ionis Pharmaceuticals, Inc. (IONS)
27.31
-1.02
(-3.60%)
USD |
NASDAQ |
Nov 12, 16:00
27.62
+0.31
(+1.14%)
After-Hours: 07:24
Ionis Pharmaceuticals Max Drawdown (5Y) : 70.27% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 70.27% |
| September 30, 2026 | 70.27% |
| August 31, 2026 | 70.27% |
| July 31, 2026 | 70.27% |
| June 30, 2026 | 70.27% |
| May 31, 2026 | 70.27% |
| April 30, 2026 | 70.27% |
| March 31, 2026 | 70.27% |
| February 28, 2026 | 70.27% |
| January 31, 2026 | 70.27% |
| December 31, 2025 | 70.27% |
| November 30, 2025 | 70.27% |
| October 31, 2025 | 70.27% |
| September 30, 2025 | 70.27% |
| August 31, 2025 | 70.27% |
| July 31, 2025 | 70.27% |
| June 30, 2025 | 70.27% |
| May 31, 2025 | 70.27% |
| April 30, 2025 | 70.27% |
| March 31, 2025 | 70.27% |
| February 28, 2025 | 70.27% |
| January 31, 2025 | 70.27% |
| December 31, 2024 | 70.27% |
| November 30, 2024 | 70.27% |
| October 31, 2024 | 70.27% |
| Date | Value |
|---|---|
| September 30, 2024 | 70.27% |
| August 31, 2024 | 70.27% |
| July 31, 2024 | 70.27% |
| June 30, 2024 | 70.27% |
| May 31, 2024 | 70.27% |
| April 30, 2024 | 70.27% |
| March 31, 2024 | 70.27% |
| February 29, 2024 | 70.27% |
| January 31, 2024 | 70.27% |
| December 31, 2023 | 70.27% |
| November 30, 2023 | 70.27% |
| October 31, 2023 | 70.27% |
| September 30, 2023 | 70.27% |
| August 31, 2023 | 70.27% |
| July 31, 2023 | 70.27% |
| June 30, 2023 | 70.27% |
| May 31, 2023 | 70.27% |
| April 30, 2023 | 70.27% |
| March 31, 2023 | 70.27% |
| February 28, 2023 | 70.27% |
| January 31, 2023 | 70.27% |
| December 31, 2022 | 70.27% |
| November 30, 2022 | 70.27% |
| October 31, 2022 | 70.27% |
| September 30, 2022 | 70.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 66.41% |
| BridgeBio Pharma, Inc. | 92.80% |
| Biogen, Inc. | 72.66% |
| Ultragenyx Pharmaceutical, Inc. | 88.24% |
| Krystal Biotech, Inc. | 53.42% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -0.9590 |
| Beta (5Y) | 0.4305 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 41.84% |
| Historical Sharpe Ratio (5Y) | 0.0616 |
| Historical Sortino (5Y) | 0.1046 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 15.84% |